Moderna soars 22% on cancer vaccine breakthrough



The shares of Moderna Inc. skyrocketed more than 22% on Tuesday following the news that its collaboration with Merck on developing a cancer vaccine delivered encouraging results.

The companies said e…

About the author:

Get involved!

Fai trading in gruppo!
L'unica Academy di trading completamente gratuita per gli utenti FpMarkets

Comments

Ancora nessun commento